ERYTECH makes its 2016 Reference Document available Post author:admERY Post published:April 3, 2017 Post category:Newsroom ERYTECH today announced that it had filed on March 31, 2017 with the “Autorité des Marchés Financiers (AMF)”, its 2016 Reference Document, including the management report and the annual financial report. You Might Also Like ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021 ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 January 27, 2014 ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer April 20, 2020
ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021
ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 January 27, 2014
ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer April 20, 2020